CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 41 filers reported holding CATALYST BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,561 | +31.3% | 46,778 | -4.3% | 0.00% | – |
| Q2 2023 | $17,185 | +28.1% | 48,878 | -24.6% | 0.00% | – |
| Q1 2023 | $13,413 | +9.8% | 64,799 | +179.7% | 0.00% | – |
| Q4 2022 | $12,220 | -49.1% | 23,166 | -52.3% | 0.00% | – |
| Q3 2022 | $24,000 | -14.3% | 48,560 | +646.2% | 0.00% | – |
| Q2 2021 | $28,000 | – | 6,508 | +17977.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 36 | -99.6% | 0.00% | – |
| Q2 2020 | $55,000 | +77.4% | 9,368 | +32.0% | 0.00% | – |
| Q1 2020 | $31,000 | +416.7% | 7,095 | +688.3% | 0.00% | – |
| Q4 2019 | $6,000 | +100.0% | 900 | +28.6% | 0.00% | – |
| Q3 2019 | $3,000 | -66.7% | 700 | -17.6% | 0.00% | – |
| Q3 2018 | $9,000 | -71.0% | 849 | -30.1% | 0.00% | – |
| Q1 2018 | $31,000 | – | 1,215 | +20150.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 6 | -98.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |